Google Tag Manager. From Jul 18 Date. Through Forever Date. Art Making. At the Watershed. Director's Circle.
Gloved Porn Porn Videos
Free hun yellow page-nude gallery
By most measures, Patrick Terwee's tenure in the sordid world of Internet pornography has been a splendid success. Over the last five years, The Hun's Yellow Pages — the site he runs with his wife out of their Netherlands home — has grown into one of the most visited sites on the Internet. According to traffic statistics firm WebSideStory, The Hun draws about , unique visitors in a typical day. What's more, Terwee, a computer programmer by training, says they've built it up without buying advertising or hiring outside staff. Although Terwee won't say exactly how much he makes by selling ads on his pared-down homepage of links to free porn sites, he admits he's "not doing badly. At the very least, it's gotten him enough to finalize plans for a million-dollar, custom-built home. But lately, hanging on to the source of all that prosperity has turned into a small nightmare.
Hun Yellow Porn Videos
We use advertisers to keep The Hun a free site! Please support us by checking out what they have to offer. We have zero tolerance for bad advertisers though. If you ever run into pop-ups or redirect please contact us so we can fix that problem!
Developed in the early s, optogenetics—the combined use of genetic and optical light methods to control genes and neurons—is among the most rapidly advancing technologies in neuroscience and has the potential to revolutionize how scientists study the brain. With precisely timed pulses of light aimed at targeted tissue regions or cells, optogenetics allows researchers to trigger or block events in specific cells of living animals. In a mouse with a paw made hypersensitive to touch, for instance, the pain response can be eliminated by shining yellow light on the affected paw, cells in which have been targeted to express a type of light-sensitive microbial protein known as opsin. The first human trial involving optogenetics began in and was designed to explore the potential use of the technology to treat patients affected by the hereditary eye disease retinitis pigmentosa.